New Treatments for Systemic Sclerosis
Author Information
Author(s): GISELE ZANDMAN-GODDARD, NURIT TWEEZER-ZAKS, YEHUDA SHOENFELD
Primary Institution: Sheba Medical Center, Tel-Hashomer; Sackler Faculty of Medicine, Tel-Aviv University, Israel
Hypothesis
Can new therapeutic strategies improve outcomes for patients with systemic sclerosis?
Conclusion
Novel therapies for systemic sclerosis show potential for improving disease outcomes, but further research is needed.
Supporting Evidence
- New treatments for systemic sclerosis have shown potential benefits in improving skin tightness and other symptoms.
- Calcium channel blockers and other medications may help with Raynaud's phenomenon in systemic sclerosis patients.
- Intravenous immunoglobulin treatment has been associated with significant decreases in skin scores in some patients.
Takeaway
Doctors are trying new medicines to help people with a disease called systemic sclerosis, which makes their skin tight and can cause other health problems.
Methodology
The review analyzed various clinical trials and studies on treatments for systemic sclerosis from 1999 to April 2005.
Potential Biases
Potential biases in reporting and selection of studies may affect the conclusions drawn.
Limitations
The rarity of systemic sclerosis limits the ability to conduct large control studies for evidence-based treatment.
Participant Demographics
Patients included in the studies had varying forms of systemic sclerosis, including early diffuse and limited disease.
Statistical Information
P-Value
p<0.009
Confidence Interval
95% CI 215.71, 20.91
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website